You may be correct, but this is a strange thread. The original post asks for clarification on the notice of effectiveness, and the reply and subsequent discussion (other than my posts and yours) is about the effectiveness of SRPT's technology and drug candidates. That is undeniably peculiar.
I sold a few shares yesterday (not at the top, but close enough), and I will continue to look for opportunities to lighten up a bit. I could buy those shares back today and pocket a small profit, but I probably won't. I still own enough for the time being.